CASPANELLO, AMALIA RITA
CASPANELLO, AMALIA RITA
Dipartimento di Medicina Clinica e Sperimentale
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease
2023-01-01 Asero, C.; Giandalia, A.; Cacciola, I.; Morace, C.; Lorello, G.; Caspanello, A. R.; Alibrandi, A.; Squadrito, G.; Russo, G. T.
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease
2023-01-01 Asero, Clelia; Giandalia, Annalisa; Cacciola, Irene; Morace, Carmela; Lorello, Giuseppe; Caspanello, AMALIA RITA; Alibrandi, Angela; Squadrito, Giovanni; Russo, Giuseppina T.
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance
2023-01-01 Stella Franzè, Maria; Filomia, Roberto; Caccamo, Gaia; Pitrone, Concetta; Alibrandi, Angela; Saitta, Carlo; Caspanello, AMALIA RITA; Asero, Clelia; Arcadi, Vittoria; Raimondo, Giovanni; Cacciola, Irene
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance
2022-01-01 Franzè, Maria Stella; Filomia, Roberto; Caccamo, Gaia; Pitrone, Concetta; Alibrandi, Angela; Saitta, Carlo; Caspanello, Amalia Rita; Asero, Clelia; Arcadi, Vittoria; Raimondo, Giovanni; Cacciola, Irene
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease | 1-gen-2023 | Asero, C.; Giandalia, A.; Cacciola, I.; Morace, C.; Lorello, G.; Caspanello, A. R.; Alibrandi, A.; Squadrito, G.; Russo, G. T. | |
| High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease | 1-gen-2023 | Asero, Clelia; Giandalia, Annalisa; Cacciola, Irene; Morace, Carmela; Lorello, Giuseppe; Caspanello, AMALIA RITA; Alibrandi, Angela; Squadrito, Giovanni; Russo, Giuseppina T. | |
| Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance | 1-gen-2023 | Stella Franzè, Maria; Filomia, Roberto; Caccamo, Gaia; Pitrone, Concetta; Alibrandi, Angela; Saitta, Carlo; Caspanello, AMALIA RITA; Asero, Clelia; Arcadi, Vittoria; Raimondo, Giovanni; Cacciola, Irene | |
| Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance | 1-gen-2022 | Franzè, Maria Stella; Filomia, Roberto; Caccamo, Gaia; Pitrone, Concetta; Alibrandi, Angela; Saitta, Carlo; Caspanello, Amalia Rita; Asero, Clelia; Arcadi, Vittoria; Raimondo, Giovanni; Cacciola, Irene |